Past Funding Woes, Thallion Gets Cash, E. Coli Drug Partner

Dec. 23, 2009

By Catherine Hollingsworth

Athersys, Pfizer Agree to Develop Stem Cell Therapy in $111M Deal

Dec. 22, 2009

By Catherine Hollingsworth

FluGen Hopes to Take the 'Ouch' Factor Out of Vaccine Delivery

Dec. 18, 2009

By Catherine Hollingsworth

Start-up Afferent Licenses Roche Pain Drug Program

Dec. 17, 2009

By Catherine Hollingsworth

Array to Get $60M Up Front in Phase I GKA Deal with Amgen

Dec. 16, 2009

By Catherine Hollingsworth

Cubist Catches Takeover Bug: $92.5M Gets Calixa, Antibiotic

Dec. 15, 2009

By Catherine Hollingsworth

Dendreon: $356M Sale to Make Provenge, Gear Up for Launch

Dec. 14, 2009

By Catherine Hollingsworth

New Trial a Show of Confidence for Oncothyreon Cancer Vaccine

Dec. 11, 2009

By Catherine Hollingsworth

NewCo News: Therasis Aims High, Launches New Systems Biology Approach

Dec. 10, 2009

By Catherine Hollingsworth

Karo Bio, Seeking Partners, Gets $23M in Rights Offering

Dec. 10, 2009

By Catherine Hollingsworth